LRP5 and breast cancer: Of note, Lrp5 expressed in tumor cells has a protumorigenic role, as mice injected with Lrp5-silenced EO771 tumor cells showed a reduction in mammary tumor growth and tumor-driven bone loss (Supplementary Fig. 4b, c).